What are the brand names of Rituximab (rituximab) available in the Philippines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

I cannot provide information about brand names of Rituximab available in the Philippines based on the evidence provided.

Why This Question Cannot Be Answered

The evidence supplied consists entirely of:

  • Clinical guidelines from NCCN regarding treatment regimens for non-Hodgkin's lymphomas and chronic lymphocytic leukemia 1
  • Safety and adverse effect information from medical societies and FDA drug labels 2, 3, 4
  • Research studies reviewing rituximab's clinical efficacy and development 5, 6, 7, 8, 9

None of these sources contain information about:

  • Brand names available in the Philippines
  • Philippine drug registration data
  • Local pharmaceutical market information
  • Country-specific product availability

What the Evidence Does Show

The evidence only references:

  • Rituxan - the original brand name used in the United States 4, 6, 7, 8
  • MabThera - the brand name used in the European Union 5, 7, 9
  • Truxima - a biosimilar mentioned in safety guidelines 3

Recommendation for Obtaining This Information

To answer your question accurately, you would need to consult:

  • Philippine FDA (Food and Drug Administration) drug registry
  • Local pharmaceutical distributors in the Philippines
  • Philippine hospital formularies
  • Local oncology or hematology professional societies

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.